Development of Pbpk Models for Pfoa and Pfos for Human Pregnancy and Lactation Life Stages
暂无分享,去创建一个
Harvey J Clewell | Melvin E Andersen | Matthew P Longnecker | Anne E. Loccisano | Jerry L. Campbell | M. Longnecker | M. Andersen | H. Clewell | Anne E Loccisano | Jerry L Campbell | J. Campbell
[1] S. Mabury,et al. Disposition of perfluorinated acid isomers in sprague‐dawley rats; Part 1: Single dose , 2009, Environmental toxicology and chemistry.
[2] Harvey J Clewell,et al. Evaluation of placental and lactational pharmacokinetics of PFOA and PFOS in the pregnant, lactating, fetal and neonatal rat using a physiologically based pharmacokinetic model. , 2012, Reproductive toxicology.
[3] L. Notarianni. Plasma Protein Binding of Drugs in Pregnancy and in Neonates , 1990, Clinical pharmacokinetics.
[4] M. Neville,et al. Physiology and endocrine changes underlying human lactogenesis II. , 2001, The Journal of nutrition.
[5] Harvey J Clewell,et al. Time dependencies in perfluorooctylacids disposition in rat and monkeys: a kinetic analysis. , 2008, Toxicology letters.
[6] G. Olsen,et al. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[7] Marie Aune,et al. Exposure of Perfluorinated Chemicals through Lactation: Levels of Matched Human Milk and Serum and a Temporal Trend, 1996–2004, in Sweden , 2006, Environmental health perspectives.
[8] C. Lau,et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[9] J. Wambaugh,et al. Modeling single and repeated dose pharmacokinetics of PFOA in mice. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[10] Jane Alcorn,et al. Pharmacokinetics in the newborn. , 2003, Advanced drug delivery reviews.
[11] Konrad Hungerbühler,et al. Estimating Consumer Exposure to PFOS and PFOA , 2008, Risk analysis : an official publication of the Society for Risk Analysis.
[12] Harvey J Clewell,et al. Application of a physiologically based pharmacokinetic model for isopropanol in the derivation of a reference dose and reference concentration. , 2002, Regulatory toxicology and pharmacology : RTP.
[13] N. Kudo,et al. Rat Organic Anion Transporter 3 and Organic Anion Transporting Polypeptide 1 Mediate Perfluorooctanoic Acid Transport , 2007 .
[14] Fumio Okada,et al. Perfluorooctane Sulfonate (PFOS) and Related Perfluorinated Compounds in Human Maternal and Cord Blood Samples: Assessment of PFOS Exposure in a Susceptible Population during Pregnancy , 2004, Environmental health perspectives.
[15] L. S. Haug,et al. Changes in concentrations of perfluorinated compounds, polybrominated diphenyl ethers, and polychlorinated biphenyls in Norwegian breast-milk during twelve months of lactation. , 2010, Environmental science & technology.
[16] A. Koizumi,et al. Human organic anion transporter hOAT4 is a transporter of perfluorooctanoic acid. , 2009, Basic & clinical pharmacology & toxicology.
[17] Kevin C Jones,et al. A first global production, emission, and environmental inventory for perfluorooctane sulfonate. , 2009, Environmental science & technology.
[18] A. Calafat,et al. Rate of Decline in Serum PFOA Concentrations after Granular Activated Carbon Filtration at Two Public Water Systems in Ohio and West Virginia , 2009, Environmental health perspectives.
[19] K. Teo,et al. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. , 2008, Environmental research.
[20] G. Olsen,et al. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. , 2009, Reproductive toxicology.
[21] E. Perucca,et al. Plasma Protein Binding of Drugs in Pregnancy , 1982, Clinical pharmacokinetics.
[22] R H Ophaug,et al. Metabolic Handling of Perfluorooctanoic Acid in Rats , 1980, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[23] W. Dunlop. Renal physiology in pregnancy. , 1979, Postgraduate medical journal.
[24] W. Dunlop,et al. SERIAL CHANGES IN RENAL HAEMODYNAMICS DURING NORMAL HUMAN PREGNANCY , 1981, British journal of obstetrics and gynaecology.
[25] Timothy R Church,et al. Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006. , 2008, Environmental science & technology.
[26] John F Wambaugh,et al. Comparative pharmacokinetics of perfluorononanoic acid in rat and mouse. , 2011, Toxicology.
[27] J M Rogers,et al. Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. , 2005, Birth defects research. Part B, Developmental and reproductive toxicology.
[28] C. Lau,et al. Perfluoroalkyl acids: a review of monitoring and toxicological findings. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[29] K. Kannan,et al. Distribution of perfluorochemicals between sera and milk from the same mothers and implications for prenatal and postnatal exposures. , 2011, Environmental pollution.
[30] D. Ehresman,et al. Roles of rat renal organic anion transporters in transporting perfluorinated carboxylates with different chain lengths. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[31] Trends in intake of energy and macronutrients--United States, 1971-2000. , 2004, MMWR. Morbidity and mortality weekly report.
[32] E. A. Sims,et al. Serial studies of renal function during pregnancy and the puerperium in normal women. , 1958, The Journal of clinical investigation.
[33] R. Setzer,et al. Pharmacokinetic modeling of perfluorooctanoic acid during gestation and lactation in the mouse. , 2009, Reproductive toxicology.
[34] S. Fenton,et al. Analysis of PFOA in dosed CD-1 mice. Part 2. Disposition of PFOA in tissues and fluids from pregnant and lactating mice and their pups. , 2009, Reproductive toxicology.
[35] L. Shaw,et al. Community Exposure to Perfluorooctanoate: Relationships Between Serum Concentrations and Exposure Sources , 2006, Journal of occupational and environmental medicine.
[36] M. Stanton,et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[37] Kouji Harada,et al. Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. , 2005, Environmental research.
[38] H Fromme,et al. Perfluorooctane sulphonate (PFOS) and perfluorooctanoic acid (PFOA) in human breast milk: results of a pilot study. , 2008, International journal of hygiene and environmental health.
[39] Martin Kraft,et al. Biomonitoring of Perfluorinated Compounds in Children and Adults Exposed to Perfluorooctanoate-Contaminated Drinking Water , 2008, Environmental health perspectives.
[40] Rolf U. Halden,et al. Cord Serum Concentrations of Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoate (PFOA) in Relation to Weight and Size at Birth , 2007, Environmental health perspectives.
[41] M. Delp,et al. Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.
[42] J. Giesy,et al. Trans-placental transfer of thirteen perfluorinated compounds and relations with fetal thyroid hormones. , 2011, Environmental science & technology.
[43] Reiko Kishi,et al. Correlations between Prenatal Exposure to Perfluorinated Chemicals and Reduced Fetal Growth , 2008, Environmental health perspectives.
[44] Geary W Olsen,et al. Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. , 2007, Environmental research.
[45] Mark J. Strynar,et al. Polyfluorinated compounds: past, present, and future. , 2011, Environmental science & technology.
[46] Tim Morris,et al. Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.
[47] J. Raymer,et al. Concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) and their associations with human semen quality measurements. , 2012, Reproductive toxicology.
[48] R. G. York,et al. Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. , 2005, Toxicology.
[49] T. Sisson,et al. The blood volume of infants. , 1959, The Journal of pediatrics.
[50] Yoichi Kawashima,et al. Tissue distribution and hepatic subcellular distribution of perfluorooctanoic acid at low dose are different from those at high dose in rats. , 2007, Biological & pharmaceutical bulletin.
[51] F. Krauer,et al. Drug disposition and pharmacokinetics in the maternal-placental-fetal unit. , 1980, Pharmacology & therapeutics.
[52] L. S. Haug,et al. Characterisation of human exposure pathways to perfluorinated compounds--comparing exposure estimates with biomarkers of exposure. , 2011, Environment International.
[53] M. Beckmann,et al. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study , 2007, International archives of occupational and environmental health.
[54] M. V. van Gemert,et al. Regulation of amniotic fluid volume. , 2007, Placenta.
[55] C. Lau,et al. The developmental toxicity of perfluoroalkyl acids and their derivatives. , 2004, Toxicology and applied pharmacology.
[56] Z. Cai,et al. Comparison on gestation and lactation exposure of perfluorinated compounds for newborns. , 2011, Environment international.
[57] J. Wambaugh,et al. Modeling single and repeated dose pharmacokinetics of PFOA in mice , 2009 .
[58] Harvey J Clewell,et al. Evaluation and prediction of pharmacokinetics of PFOA and PFOS in the monkey and human using a PBPK model. , 2011, Regulatory toxicology and pharmacology : RTP.
[59] Gerald L Kennedy,et al. Perfluorooctanoate: Placental and lactational transport pharmacokinetics in rats. , 2005, Toxicology.
[60] Anne E. Loccisano,et al. Comparison and evaluation of pharmacokinetics of PFOA and PFOS in the adult rat using a physiologically based pharmacokinetic model. , 2012, Reproductive toxicology.
[61] R. G. York,et al. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. , 2005, Toxicology.
[62] Shumei S. Guo,et al. 2000 CDC Growth Charts for the United States: methods and development. , 2002, Vital and health statistics. Series 11, Data from the National Health Survey.
[63] Melvin E Andersen,et al. Perfluoroalkyl acids and related chemistries--toxicokinetics and modes of action. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[64] Jonathan P. Benskin,et al. Isomer Profiles of Perfluorochemicals in Matched Maternal, Cord, and House Dust Samples: Manufacturing Sources and Transplacental Transfer , 2011, Environmental health perspectives.
[65] Hermann Fromme,et al. Perfluorinated compounds--exposure assessment for the general population in Western countries. , 2009, International journal of hygiene and environmental health.
[66] M S Christian,et al. Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds. , 2001, International journal of toxicology.
[67] A. Calafat,et al. Polyfluoroalkyl chemicals in the serum and milk of breastfeeding women. , 2009, Reproductive toxicology.
[68] M. Zeilmaker,et al. Levels of perfluorinated compounds in food and dietary intake of PFOS and PFOA in the Netherlands. , 2010, Journal of agricultural and food chemistry.
[69] N. Kudo,et al. Sex hormone-regulated renal transport of perfluorooctanoic acid. , 2002, Chemico-biological interactions.
[70] H. Kalkwarf,et al. Lactation, weaning, and calcium supplementation: effects on body composition in postpartum women. , 2004, The American journal of clinical nutrition.
[71] C. Lau,et al. Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[72] Martin Scheringer,et al. Estimating the contribution of precursor compounds in consumer exposure to PFOS and PFOA. , 2008, Chemosphere.
[73] S. Mabury,et al. Disposition of perfluorinated acid isomers in sprague‐dawley rats; Part 2: Subchronic dose , 2009, Environmental toxicology and chemistry.
[74] G. W. Jepson,et al. Binding of perfluorooctanoic acid to rat and human plasma proteins. , 2003, Chemical research in toxicology.
[75] Vera Thomas. Biological-Mathematical Modeling of Chronic Toxicity. , 1981 .
[76] L. Brown,et al. Intake of tapwater and total water by pregnant and lactating women. , 1991, American journal of public health.
[77] Ian T Cousins,et al. Tracking the pathways of human exposure to perfluorocarboxylates. , 2009, Environmental science & technology.
[78] H. Kusuhara,et al. Gender Difference in the Urinary Excretion of Organic Anions in Rats , 2002, Journal of Pharmacology and Experimental Therapeutics.
[79] B. Koletzko,et al. Pre- and postnatal exposure to perfluorinated compounds (PFCs). , 2010, Environmental science & technology.
[80] Gloria B Post,et al. Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature. , 2012, Environmental research.
[81] J. V. Vanden Heuvel,et al. Lack of evidence for perfluorodecanoyl- or perfluorooctanoyl-coenzyme A formation in male and female rats. , 1992, Journal of biochemical toxicology.
[82] D. Barceló,et al. Infant exposure of perfluorinated compounds: levels in breast milk and commercial baby food. , 2010, Environment international.
[83] Harvey J Clewell,et al. Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys--probing the determinants of long plasma half-lives. , 2006, Toxicology.
[84] Xing Han,et al. Organic anion transporting polypeptide (Oatp) 1a1-mediated perfluorooctanoate transport and evidence for a renal reabsorption mechanism of Oatp1a1 in renal elimination of perfluorocarboxylates in rats. , 2009, Toxicology letters.
[85] C. Lau,et al. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[86] H. Schouten,et al. Maternal Volume Homeostasis in Early Pregnancy in Relation to Fetal Growth Restriction , 1995, Obstetrics and gynecology.
[87] C. Lau. Perfluoroalkyl acids: recent activities and research progress. , 2009, Reproductive toxicology.
[88] Jørn Olsen,et al. Perfluorinated Chemicals and Fetal Growth: A Study within the Danish National Birth Cohort , 2007, Environmental health perspectives.
[89] J. Kim,et al. Molecular Cloning and Characterization of Multispecific Organic Anion Transporter 4 Expressed in the Placenta* , 2000, The Journal of Biological Chemistry.
[90] Xing Han,et al. Characterization of cellular uptake of perfluorooctanoate via organic anion-transporting polypeptide 1A2, organic anion transporter 4, and urate transporter 1 for their potential roles in mediating human renal reabsorption of perfluorocarboxylates. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[91] John W. Froehlich,et al. Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers , 2007, Environmental health perspectives.
[92] J. Johnson,et al. Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of ammonium [14C]perfluorooctanoate or potassium [14C]perfluorooctanesulfonate. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[93] J. V. Vanden Heuvel,et al. Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats. , 1991, Journal of biochemical toxicology.
[94] Y. Kanai,et al. Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid. , 2008, Basic & clinical pharmacology & toxicology.
[95] S. Tittlemier,et al. Dietary exposure of Canadians to perfluorinated carboxylates and perfluorooctane sulfonate via consumption of meat, fish, fast foods, and food items prepared in their packaging. , 2007, Journal of agricultural and food chemistry.
[96] A. Calafat,et al. Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[97] P. Rosso,et al. Time Course of Maternal Plasma Volume and Hormonal Changes in Women With Preeclampsia or Fetal Growth Restriction , 2006, Hypertension.
[98] Ian T Cousins,et al. Sources, fate and transport of perfluorocarboxylates. , 2006, Environmental science & technology.
[99] L. Hanssen,et al. Perfluorinated compounds in maternal serum and cord blood from selected areas of South Africa: results of a pilot study. , 2010, Journal of environmental monitoring : JEM.
[100] N. Milman,et al. Iron status and iron balance during pregnancy. A critical reappraisal of iron supplementation , 1999, Acta obstetricia et gynecologica Scandinavica.
[101] D. Medeiros,et al. Dietary Reference Intakes: the Essential Guide to Nutrient Requirements edited by JJ Otten, JP Hellwig, and LD Meyers, 2006, 560 pages, hardcover, $44.96. The National Academies Press, Washington, DC. , 2007 .
[102] G. Kennedy,et al. Renal elimination of perfluorocarboxylates (PFCAs). , 2012, Chemical research in toxicology.
[103] A. Calafat,et al. Polyfluoroalkyl Chemicals in the U.S. Population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and Comparisons with NHANES 1999–2000 , 2007, Environmental health perspectives.
[104] H J Clewell,et al. Evaluation of the uncertainty in an oral reference dose for methylmercury due to interindividual variability in pharmacokinetics. , 1999, Risk analysis : an official publication of the Society for Risk Analysis.
[105] M. Heinig,et al. Adequacy of energy intake among breast-fed infants in the DARLING study: relationships to growth velocity, morbidity, and activity levels. Davis Area Research on Lactation, Infant Nutrition and Growth. , 1991, The Journal of pediatrics.
[106] Harvey J Clewell,et al. Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation. , 2003, Regulatory toxicology and pharmacology : RTP.
[107] A. Telek,et al. The blood volume of infants. I. The full-term infant in the first year of life. , 1959, The Journal of pediatrics.